Complement Blockade, a New Therapeutic Approach in Malignant Hypertension Cover

.blurhash-client-img { display: none !important; }

Complement Blockade, a New Therapeutic Approach in Malignant Hypertension

Internal Medicine

Volume 21 (2024): Issue 1 (March 2024)

By: Camelia-Adriana Achim, Cătălina Voicu-Titere, Georgiana Aurelia Nae, Daniela-Gabriela Florescu, Rareș-Vasilică Moisa and Gener Ismail

Open Access

|Mar 2024

Authors

Camelia-Adriana Achim

“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania

Cătălina Voicu-Titere

Department of Nephrology, Fundeni Clinical Institute, Bucharest, Romania

Georgiana Aurelia Nae

Department of Nephrology, County Emergency Hospital Giurgiu, Giurgiu, Romania

Daniela-Gabriela Florescu

Department of Nephrology, Fundeni Clinical Institute, Bucharest, Romania

Rareș-Vasilică Moisa

Department of Nephrology, Fundeni Clinical Institute, Bucharest, Romania

Gener Ismail

“Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania

DOI: https://doi.org/10.2478/inmed-2024-0283 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818

Journal RSS Feed

Language: English

Page range: 105 - 115

Published on: Mar 29, 2024

Published by: Romanian Society of Internal Medicine

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

hemolytic uremic syndrome,

malignant arterial hypertension

Related subjects:

Clinical medicine,

Internal medicine,

Internal medicine, other,

Gastroenterology,

© 2024 Camelia-Adriana Achim, Cătălina Voicu-Titere, Georgiana Aurelia Nae, Daniela-Gabriela Florescu, Rareș-Vasilică Moisa, Gener Ismail, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous article Volume 21 (2024): Issue 1 (March 2024)